ArticleThe Journal of pharmacology and experimental therapeutics2014

The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype.

J Brek Eaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.